Conferences - Results from #9040

Viewing 9041-9060 of 11487 articles

AUA 2017: Radical Prostatectomy Versus Observation for Early Prostate Cancer: Follow-Up Results of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)

AUA 2017: State-of-the-Art Lecture: Circulating Tumor Cells

AUA 2017: Racial Disparities and Genetic Variabilities in Prostate Cancer

AUA 2017: State-of-the-Art Lecture: Immunotherapy for Bladder Cancer

AUA 2017: Highlights of Urologic Oncology Research

AUA 2017: Modified 5-item frailty index is associated with increased healthcare resource utilization following elective minimally invasive radical nephrectomy

AUA 2017: Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥ 4 cm)? A propensity score matched study

AUA 2017: Influence of Statin Intake on PSA Values, Risk of Prostate Cancer Development and Survival in a Prospective Screening Trial Cohort (ERSPC)

AUA 2017: Multiparametric MRI represents an added value but not a substitute of follow-up biopsies in patients on active surveillance for low-risk prostate cancer

AUA 2017: 11C-Choline versus 68ga-PSMA PET/CT scan for the detection of nodal recurrence from prostate cancer: results from a large, multi-institutional salvage lymph node dissection series

AUA 2017: Elderly Prostate Cancer Patients Have A Worse Prognosis Than Younger Patients: A Population-based Study In The Netherlands

AUA 2017: Statin Use, Serum Lipid Levels and Prostate Inflammation; Results from the Reduce Study

AUA 2017: Fasting Blood Glucose and Prostate Cancer Risk in the Finnish Randomized Study of Screening for Prostate Cancer

AUA 2017: Plenary Next Frontier

AUA 2017: Procept BioRobotics’ Aquablation Shows Superior Results vs. TURP in WATER Blinded Randomized Trial for BPH

AUA 2017: Clinical Destiny of Indeterminate Pulmonary Nodules in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder

AUA 2017: The Effect of Prostate Cancer Treatment on Patient Reported Urinary and Sexual Function Varies by Disease Severity: 3-year Results From the Ceasar Study

AUA 2017: Use of Adjuvant Chemotherapy In Patients With Advanced Bladder Cancer After Neoadjuvant Chemotherapy

AUA 2017: Dose Dense Mvac Prior To Radical Cystectomy: A Retrospective Multi-institutional Experience

AUA 2017: Genomic Differences Between “Primary” And “Secondary” Muscle Invasive Bladder Cancer: Implications For Neoadjuvant Chemotherapy

448
449
450
451
452
453
454
455
456
457